No-Spa - olelo ao no ka hoʻohana.

laʻau heluna palapala

Ka makaukau i ke hua mai i loko o nā 'ano apau loa - na papa, a injectable pāʻoihana.

Biconvex, a papa, me ka alani a me he omaomao iki waihoʻoluʻu. Ma kēlā me kēia papa me kekahi lima o ke kumukuai o omaka «Spa».

nā mea hoʻohui:

Main 'Oponopono:

• drotaverina hydrochloride - 40 mg (1 uku pila.).

Excipients:

• palaoa pia;
• makanekiuma stearate;
• lactose monohydrate;
• polyvidone.

Nospanum ampoules. Aʻo mai nei i ka lāʻau pāʻoihana hiki ke hoʻohana 'ia no nā intramuscular a me ka intravenous infusions. Ke kākoʻo pāʻoihana ua he omaomao iki-melemele, ka aniani moakaka.

nā mea hoʻohui:

Main 'Oponopono:

• drotaverina hydrochloride - 20/40 mg (1 ml ampoule ole 1 niioaaonoaaiii).

Excipients:

• ethanol 96%;
• paʻakai metabisulfite;
• wai no ka pahu kui.

Ke pharmacological hana o ka lāʻau "No-Spa"

Alakaʻi hākālia nō i ole-Spa mea miotropnym antispasmodic. I ka papa kuhikuhiEʻeleu waiwai mea drotaverine isoquinolone derivative a me ka hōʻike laumania Muscle spasmolytic hana, a ua hana ma ka inhibiting phosphodiesterase 4. Inhibition o keia'ūhū ke hoomahuahua i ka maʻiʻo o kahi e hoʻomoana ai i loko o ke koko, a hiki i ka inactivate kinase kaula myosin. He ka la mahope, e alakai i ka i laumania Muscle hoʻomaha.

An'ūhū e hydrolyzes kahi i hoʻomoana ai i nāʻalā Muscle keena o ka myocardium a me ka ipu koko, o ke phosphodiesterase isoenzyme 3 - ia hiʻona he 'ano kiʻekiʻe hopenaʻoi loa me he antispasmodic, no ka mea, i loko o ka mea, aohe mea i hai ia ma luna o ka mea'ōnaehana mānowai koko'ōnaehana, e like me ka hua'ōlelo i makemake mea'ōnaehana mānowai koko ole.

Nospanum mana i loko o nā ala apuupuu Muscle spasms, a me ko mākou hopohopo etiology. Eia kekahi, nānā 'ole o ka' ano o ka autonomic innervation o ka lāʻau 'ke hana ma luna o nāʻalā Muscle' ole o ka biliary'āpana, gastrointestinal'āpana, a me ka mea'ōnaehana mānowai koko urogenital nenoai. No-Spa hiki i ka hoʻoikaika 'ana i ke koko holo, a, i ke aloha i kona vasodilating kanawai.

No-Spa - hoike

Ua Ua hoʻohana 'ia e like me ka papa kuhikuhi kumu o ka kēia mau maʻi:

• cholecystitis;
• cholelithiasis;
• pericholecystitis;
• cholangitis;
• papillitis;
• cystitis;
• pyelitis;
• tenesmus o ka bladder;
• i pono like, e hoʻonui i ka uku o cervical dilatation.

Ua Ua hoʻohana 'ia e like me he kokua no ka mea kēia mau maʻi:

• gastritis;
• cardia spasm;
• pyloric spasm;
• colitis;
• enterocolitis;
• 'ōpū ulcers;
• duodenal ulcer;
• dysmenorrhea;
• headaches;
• ikaika hana mau eha.

ʻaoʻao 'ole o ka lāʻau Nospanum

Na olelo e wehewehe i nā mea a pau e hikiʻaoʻao 'ole ma ka pili ana i na nenoai likeʻole a me nā loko.

Hikiʻaoʻao 'ole, mai ka hana mai o ka lāʻau, mai ka gastrointestinal'āpana.

• constipation;
• nausea.

Hikiʻaoʻao 'ole, mai ka hana mai o ka lāʻau, mai ka CNS:

• Kanikani'āʻula;
• pōniuniu;
• headache.

Hikiʻaoʻao 'ole o ka lāʻau ma ka CAS.

• hypertension;
• tachycardia.

Otherʻaoʻao 'ole:

• allergic reactions i eiiiiiaiou.

Contraindications i ka lāʻau akā shpa

Alakaʻi ho'ākāka i ke kēia contraindications:

• hepatic aʻaʻa puʻuwai ole;
• naau ole;
• mai ai i 1 makahiki;
• pā lonoaʻili i ka drotaverine 'ole' ē aʻe 'ona o ka hoʻomanaʻo;
• arterial hypotension lāʻau e hoʻohana me ka mālama nui.

Pono e lawelawe ia ka lāʻau a hiki i ke ahonui wale nō i loko o ka supine kulana, no ka mea, ma keia hihia he mea he pilikia o ka'opi.

Uluwehi O overdose Nospanum

InstructionʻAʻohe 'ike ma na hihia o ka overdose E like me ka laau lapaau.

Uluwehi O ke hana kūleʻa me nā lapaʻauʻia

Oiai ka hoʻohana o levodopa Nospanum ho'ēmi i kā kona Anati-Parkinsonian hopena.